Antidepressants are effective in reducing symptoms of generalized anxiety disorder (GAD), a major new review confirms. However, it also reveals a critical gap in research: The long-term effects of these widely prescribed medications remain unclear.
Significant Relief
A Cochrane review analyzed 37 randomized controlled trials involving more than 12,000 participants, comparing the effectiveness of antidepressants to placebo.Most of the trials were conducted in high-income countries, such as the United States and various European nations, and the participant sample was approximately 60 percent female, aligning with the known clinical prevalence of GAD.
Antidepressants were 41 percent more effective than a placebo in alleviating anxiety symptoms in people with moderate to severe GAD, according to the findings. There was no significant difference in dropout rates between the placebo and treatment groups, suggesting that these medications are generally well-tolerated.
Antidepressants effectively reduced anxiety symptoms in people with GAD (and no other conditions) within one to three months, compared to placebo, he noted. This reduction in anxiety levels, as measured by standardized scales, is considered substantial enough to represent a noticeable positive change in a patient’s daily functioning and quality of life.
Limited Data on Long-Term Effects
Researchers emphasized the lack of sufficient data on patients with GAD who also experience other mental health conditions, a common scenario in clinical practice.“We don’t have enough information on the potential long-term benefits and harms of antidepressants, even though people often take them for years,” first author Katarina Kopcalic, who conducted the review at Western University, said in the statement. “This is an area that needs further exploration in future trials.”
The Risks of Abruptly Stopping Antidepressants
SSRIs work by increasing serotonin levels in the brain, which can help treat depression and anxiety. Serotonin is a chemical messenger that carries signals between nerve cells in the brain.There is a withdrawal syndrome that can occur from abruptly stopping an SSRI, Dr. John Christman, a psychiatrist at Northwell Zucker Hillside Hospital in Queens, New York, told The Epoch Times.
Symptoms include nausea, lightheadedness, dizziness (sometimes referred to as “brain zaps”), or a general feeling of sickness.
“It is uncomfortable, but it’s not dangerous, it’s not lethal in any kind of way,” Christman said. “The danger occurs when you have a significant anxiety issue or a depressive disorder, and you’re about to stop the medication.”
Case Study: Suicide Attempt After Discontinuation
A case study published in The Journal of Clinical Psychiatry reported a 22-year-old woman with a history of depression and anxiety who attempted suicide after abruptly stopping her long-term antidepressant medication (escitalopram/Lexapro) when she ran out and couldn’t see her doctor.Seven days after stopping the medication, she ingested a half-bottle of acetaminophen and was rushed to the emergency room.
Antidepressant Discontinuation Syndrome
Ms. A’s case report illustrates a common complication of abruptly stopping antidepressant medication known as antidepressant discontinuation syndrome (ADS).The case study noted that nearly 35 percent of patients who abruptly discontinued paroxetine (a different antidepressant) in a clinical trial experienced withdrawal symptoms.
After restarting her medication, the woman’s depressive symptoms and antidepressant withdrawal symptoms resolved within four days.
Christman emphasized that the most important thing is to have a discussion with your health care provider before stopping these kinds of medications.
“It’s okay to, at some point, maybe consider to come off an SSRI,” he said. “You don’t have to be on these things necessarily for life. You can come off of them.”







